Recurrent Angiomyofibroblastoma of the Vulva: MRI Characteristics and Long-Term Monitoring Insights.

Taiwan J Obstet GynecolOct 30, 2026
Case ReportObstetrics & GynecologyRadiology (Diagnostic)Pathology (Anatomic & Clinical)

Kuang-Yen Lee, I-Lun Shih, Jen-Chieh Lee et al.

✦ AI-curated · Sources linked

Case in brief

A 33-year-old woman presented with a painless, pedunculated right vulvar mass, excised and diagnosed pathologically as angiomyofibroblastoma (AMFB). Follow-up pelvic CT showed a small irregular enhancing lesion at the site, and MRI later demonstrated a 6.1 × 4.8 × 2.8 cm heterogeneous tumor with T2 hyperintensity, marked post-contrast enhancement, and mild diffusion restriction. Excision confirmed recurrent AMFB. She remained free of recurrence for four years after the second operation.

What made this case unusual

The case documents recurrent vulvar AMFB with MRI features including heterogeneous signal, strong enhancement, and mild diffusion restriction.

Diagnostic / clinical pearl

A new enhancing vulvar lesion after AMFB excision may represent recurrence; MRI can characterize the lesion, with pathology confirming the diagnosis.

Why it matters

The report highlights MRI monitoring as an option for patients with recurrent AMFB who are concerned about repeated surgery.

Source

PubMed · PMID 42951478

Published in Taiwan J Obstet Gynecol. This summary was written by xxcode from the publication's abstract and metadata. It is not peer reviewed and is not a substitute for the original article. For clinical decisions, review the original publication.

ShareTelegramLinkedIn

AI-generated summaries may contain errors or omissions. Verify clinically important information with the original publication.

More in Obstetrics & Gynecology

Clinical ResearchOncology (Medical)

Curative-intent management of de novo metastatic nasopharyngeal carcinoma: an evidence-based consensus guideline from the International Collaborating Oncology Organisations.

This international consensus guideline addresses curative-intent management of de novo metastatic nasopharyngeal carcinoma, a population historically treated with palliative intent.

Lancet OncolOct 29, 2026Read summary
Clinical ResearchHematology

Decitabine plus busulfan-cyclophosphamide versus busulfan-cyclophosphamide myeloablative conditioning before allogeneic haematopoietic stem cell transplantation for reducing risk of relapse in adult KMT2A‑rearranged leukaemia in China: an open-label, multicentre, randomised phase 3 trial.

This open-label, multicentre, randomised phase 3 trial compared decitabine plus busulfan-cyclophosphamide (DAC-BuCy) with BuCy conditioning before allogeneic HSCT in 130 patients aged 14–65 years with KMT2A-rearranged…

Lancet HaematolOct 30, 2026Read summary
Clinical ResearchPediatrics

Prone positioning and high-frequency oscillatory ventilation in early paediatric acute respiratory distress syndrome (PROSpect): an international, two-by-two factorial, response-adaptive, phase 3, randomised controlled trial.

PROSpect was an international, two-by-two factorial, phase 3 randomised controlled trial comparing prone with supine positioning and high-frequency oscillatory ventilation (HFOV) with conventional mechanical ventilation…

LancetOct 30, 2026Read summary

Want this personalized?

Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.

  • Your specialties
  • Your filters and thresholds
  • Clinical Research + Case Reports, tuned separately
  • Automatic weekly delivery
  • Audio and text
Create my personalized digestSee plans

Prefer listening? Personalized audio digests are available with Pro.

Stay updated for free

Get the 3 most interesting publications in one specialty each week.

Weekly email. Unsubscribe anytime.